Maryam Bigdeli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maryam Bigdeli has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Abdul Ghaffar
Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland
2 shared publicationsBart Jacobs
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), Phnom Penh, Cambodia
2 shared publicationsBruno Dujardin
Centre de Recherches en Politiques et Systèmes de Santé, Santé Internationale, School of Public Health, Université Libre de Bruxelles, Brussels, Belgium
2 shared publications- Göran Tomson
Karolinska Institutet
2 shared publications - Hafid Hachri
World Health Organization Country Office in Rabat, Rabat
2 shared publications Wim Van Damme
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
2 shared publications
Latest Publications
- 11 October 2026
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 15, e4943
Resilience Without Foundation? Interrogating Health System Governance in Shaping Health System Resilience in Haiti – A Qualitative Study of Stakeholders’ Perceptions
Background: Health system resilience (HSR) is a priority in Haiti, one of the world’s most fragile and poorly governed countries. It depends on the capacity of communities, institutions, and actors to anticipate, absorb, and adapt to shocks. Health system governance (HSG) – policy processes, institutional arrangements, and stakeholder relations – is a core determinant of HSR. This study examines how health system stakeholders in Haiti understand HSR and the role of HSG in shaping it. Methods: We conducted an exploratory qualitative study using semi‑structured interviews with 15 strategic decision‑makers, senior and operational managers, and healthcare providers in July 2023 in Port‑au‑Prince and Southern Haiti. Participants were recruited through purposive and snowball sampling. Data were analysed thematically, combining deductive codes from HSR frameworks, with inductive identification of emerging HSG themes. Social contract constructs identified in participants’ accounts informed the application of a social contract lens as an ex post interpretive framework for discussion. Results: Participants framed HSR as a collective political commitment to health systems strengthening (HSS) and advancement of an integrated health and development approach, rejecting interpretations that shift responsibility onto communities. HSG was considered foundational to HSR, with three interdependent dimensions emerging from analysis: organisational‑structural, politico‑institutional, and ethical‑citizen. Weaknesses across dimensions—including weak planning capacity, constitutional ambiguities, budget opacity, donor‑driven power asymmetries, inequitable access, limited accountability, and legitimacy gaps—were mutually reinforcing. Trust emerged as a cross‑cutting determinant. Conclusion: From a social contract perspective, coherence across HSG dimensions rather than adherence to isolated principles appears to be a key condition for HSR in Haiti. Strengthening institutional capacity, credible planning, and legitimacy require simultaneous actions across these dimensions. Provider‑community trust constitutes an HSG resource on which to build. Despite the small sample and absence of community perspectives, the study offers a basis for further exploration in countries facing similar HSG challenges.
- 11 October 2026
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 15, e4943
Resilience Without Foundation? Interrogating Health System Governance in Shaping Health System Resilience in Haiti – A Qualitative Study of Stakeholders’ Perceptions
Background: Health system resilience (HSR) is a priority in Haiti, one of the world’s most fragile and poorly governed countries. It depends on the capacity of communities, institutions, and actors to anticipate, absorb, and adapt to shocks. Health system governance (HSG) – policy processes, institutional arrangements, and stakeholder relations – is a core determinant of HSR. This study examines how health system stakeholders in Haiti understand HSR and the role of HSG in shaping it. Methods: We conducted an exploratory qualitative study using semi‑structured interviews with 15 strategic decision‑makers, senior and operational managers, and healthcare providers in July 2023 in Port‑au‑Prince and Southern Haiti. Participants were recruited through purposive and snowball sampling. Data were analysed thematically, combining deductive codes from HSR frameworks, with inductive identification of emerging HSG themes. Social contract constructs identified in participants’ accounts informed the application of a social contract lens as an ex post interpretive framework for discussion. Results: Participants framed HSR as a collective political commitment to health systems strengthening (HSS) and advancement of an integrated health and development approach, rejecting interpretations that shift responsibility onto communities. HSG was considered foundational to HSR, with three interdependent dimensions emerging from analysis: organisational‑structural, politico‑institutional, and ethical‑citizen. Weaknesses across dimensions—including weak planning capacity, constitutional ambiguities, budget opacity, donor‑driven power asymmetries, inequitable access, limited accountability, and legitimacy gaps—were mutually reinforcing. Trust emerged as a cross‑cutting determinant. Conclusion: From a social contract perspective, coherence across HSG dimensions rather than adherence to isolated principles appears to be a key condition for HSR in Haiti. Strengthening institutional capacity, credible planning, and legitimacy require simultaneous actions across these dimensions. Provider‑community trust constitutes an HSG resource on which to build. Despite the small sample and absence of community perspectives, the study offers a basis for further exploration in countries facing similar HSG challenges.
- Open Access
- 1 October 2022
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 21 (S3) , 1-10
Action on the social determinants for advancing health equity in the time of COVID-19: perspectives of actors engaged in a WHO Special Initiative
Since the 2008 publication of the reports of the Commission on Social Determinants of Health and its nine knowledge networks, substantial research has been undertaken to document and describe health inequities. The COVID-19 pandemic has underscored the need for a deeper understanding of, and broader action on, the social determinants of health. Building on this unique and critical opportunity, the World Health Organization is steering a multi-country Initiative to reduce health inequities through an action-learning process in ‘Pathfinder’ countries. The Initiative aims to develop replicable and reliable models and practices that can be adopted by WHO offices and UN staff to address the social determinants of health to advance health equity. This paper provides an overview of the Initiative by describing its broad theory of change and work undertaken in three regions and six Pathfinder countries in its first year-and-a-half. Participants engaged in the Initiative describe results of early country dialogues and promising entry points for implementation that involve model, network and capacity building. The insights communicated through this note from the field will be of interest for others aiming to advance health equity through taking action on the social determinants of health, in particular as regards structural determinants.
- 1 October 2022
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 21 (S3) , 1-10
Open AccessAction on the social determinants for advancing health equity in the time of COVID-19: perspectives of actors engaged in a WHO Special Initiative
Since the 2008 publication of the reports of the Commission on Social Determinants of Health and its nine knowledge networks, substantial research has been undertaken to document and describe health inequities. The COVID-19 pandemic has underscored the need for a deeper understanding of, and broader action on, the social determinants of health. Building on this unique and critical opportunity, the World Health Organization is steering a multi-country Initiative to reduce health inequities through an action-learning process in ‘Pathfinder’ countries. The Initiative aims to develop replicable and reliable models and practices that can be adopted by WHO offices and UN staff to address the social determinants of health to advance health equity. This paper provides an overview of the Initiative by describing its broad theory of change and work undertaken in three regions and six Pathfinder countries in its first year-and-a-half. Participants engaged in the Initiative describe results of early country dialogues and promising entry points for implementation that involve model, network and capacity building. The insights communicated through this note from the field will be of interest for others aiming to advance health equity through taking action on the social determinants of health, in particular as regards structural determinants.
- Open Access
- 6 May 2021
- Published by Springer Nature in Archives of Public Health
- Vol. 79 (1) , 1-13
Comparison of appropriateness of Nutri-Score and other front-of-pack nutrition labels across a group of Moroccan consumers: awareness, understanding and food choices
Background: The front of pack nutrition label Nutri-Score, intended to help consumers orient their choices towards foods that are more favorable to health, was developed in France and applied in several European countries. Consideration is underway for its use in Morocco. This study aims to assess Moroccan consumers’ perception and objective understanding of Nutri-Score and 4 other nutritional information labels (Health Star Rating, Health warning, Reference Intakes and Multiple Trafic Light) and their impact on purchase intentions. Methods: 814 participants were asked to choose among 3 food classes (yoghurts, biscuits and cold cuts), which ones they would prefer to buy among three products with different nutritional profiles and then to rank them according to their nutritional quality. Participants first performed these tasks without a visible nutritional label, and then, after being randomized to one of five labels tested, with the nutritional label visible on front of packs. Next, the full set of tested labels was presented to the participants who were asked a series of questions regarding their preferences, the attractiveness of the labels, their perceptions, intention to use and the trustworthiness placed in the labels. Results: Compared to the Reference Intake, the Nutri-Score (OR = 2.48 [1.53–4.05], p < 0.0001), was associated with the highest improvement in the ability to correctly classify foods based on their nutritional quality. The percentage of participants who improved their food choice was higher than those who worsened it for all the labels. For yogurts and cookies, the most significant improvements were observed for the Nutri-Score and the Reference Intakes: Concerning the perception of labels, the Nutri-Score is the label that received the highest number of positive responses, whether concerning the ease of being spotted (82.2%), of being understood (74%), and to provide rapid information (68.8%). The Nutri-Score was ranked as the preferred label by 64.9% of the participants. Conclusion: The Nutri-Score appears to be the most effective nutritional information system to inform consumers about the nutritional quality of foods in Morocco, where it could constitute a useful tool to help consumers in their food choices in situations of purchase.
- 6 May 2021
- Published by Springer Nature in Archives of Public Health
- Vol. 79 (1) , 1-13
Open AccessComparison of appropriateness of Nutri-Score and other front-of-pack nutrition labels across a group of Moroccan consumers: awareness, understanding and food choices
Background: The front of pack nutrition label Nutri-Score, intended to help consumers orient their choices towards foods that are more favorable to health, was developed in France and applied in several European countries. Consideration is underway for its use in Morocco. This study aims to assess Moroccan consumers’ perception and objective understanding of Nutri-Score and 4 other nutritional information labels (Health Star Rating, Health warning, Reference Intakes and Multiple Trafic Light) and their impact on purchase intentions. Methods: 814 participants were asked to choose among 3 food classes (yoghurts, biscuits and cold cuts), which ones they would prefer to buy among three products with different nutritional profiles and then to rank them according to their nutritional quality. Participants first performed these tasks without a visible nutritional label, and then, after being randomized to one of five labels tested, with the nutritional label visible on front of packs. Next, the full set of tested labels was presented to the participants who were asked a series of questions regarding their preferences, the attractiveness of the labels, their perceptions, intention to use and the trustworthiness placed in the labels. Results: Compared to the Reference Intake, the Nutri-Score (OR = 2.48 [1.53–4.05], p < 0.0001), was associated with the highest improvement in the ability to correctly classify foods based on their nutritional quality. The percentage of participants who improved their food choice was higher than those who worsened it for all the labels. For yogurts and cookies, the most significant improvements were observed for the Nutri-Score and the Reference Intakes: Concerning the perception of labels, the Nutri-Score is the label that received the highest number of positive responses, whether concerning the ease of being spotted (82.2%), of being understood (74%), and to provide rapid information (68.8%). The Nutri-Score was ranked as the preferred label by 64.9% of the participants. Conclusion: The Nutri-Score appears to be the most effective nutritional information system to inform consumers about the nutritional quality of foods in Morocco, where it could constitute a useful tool to help consumers in their food choices in situations of purchase.
- Open Access
- 29 September 2020
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 18 (1) , 1-12
Policy dialogue and participation: a new way of crafting a national health financing strategy in Morocco
Background: Policy dialogue for health policies has started to gain importance in recent years, especially for complex issues such as health financing. Moroccan health financing has faced several challenges during the last years. This study aims to document the Moroccan experience in developing a consolidated health financing strategy according to the policy dialogue approach. It especially considers the importance of conceptualising this process in the Moroccan context. Method: We documented the process of developing a health financing strategy in Morocco. It concerned four steps, as follows: (1) summarising health financing evidence in preparation of the policy dialogue; (2) organising the health policy dialogue process with 250 participants (government, private sector, NGOs, civil society, parliamentarians, technical and financial partners); (3) a technical workshop to formulate the strategy actions; and (4) an ultimate workshop for validation with decision-makers. The process lasted 1 year from March 2019 to February 2020. We have reviewed all documents related to the four steps of the process through our active participation in the policy debate and the documentation of two technical workshops to produce the strategy document. Results: The policy dialogue approach showed its usefulness in creating convergence among all health actors to define a national shared vision on health financing in Morocco. There was a high political commitment in the process and all actors officially adopted recommendations on health financing actions. A strategy document produced within a collaborative approach was the final output. This experience also marked a shift from previous top-down approaches in designing health policies for more participation and inclusion. The evidence synthesis played a crucial role in facilitating the debate. The collaborative approach seems to work in favouring national consensus on practical health financing actions. Conclusion: The policy dialogue process adopted for health financing in Morocco helped to create collective ownership of health financing actions. Despite the positive results in terms of national mobilisation around the health financing vision in Morocco, there is a need to institutionalise the policy dialogue with a more decentralised approach to consider subnational specificities.
- 29 September 2020
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 18 (1) , 1-12
Open AccessPolicy dialogue and participation: a new way of crafting a national health financing strategy in Morocco
Background: Policy dialogue for health policies has started to gain importance in recent years, especially for complex issues such as health financing. Moroccan health financing has faced several challenges during the last years. This study aims to document the Moroccan experience in developing a consolidated health financing strategy according to the policy dialogue approach. It especially considers the importance of conceptualising this process in the Moroccan context. Method: We documented the process of developing a health financing strategy in Morocco. It concerned four steps, as follows: (1) summarising health financing evidence in preparation of the policy dialogue; (2) organising the health policy dialogue process with 250 participants (government, private sector, NGOs, civil society, parliamentarians, technical and financial partners); (3) a technical workshop to formulate the strategy actions; and (4) an ultimate workshop for validation with decision-makers. The process lasted 1 year from March 2019 to February 2020. We have reviewed all documents related to the four steps of the process through our active participation in the policy debate and the documentation of two technical workshops to produce the strategy document. Results: The policy dialogue approach showed its usefulness in creating convergence among all health actors to define a national shared vision on health financing in Morocco. There was a high political commitment in the process and all actors officially adopted recommendations on health financing actions. A strategy document produced within a collaborative approach was the final output. This experience also marked a shift from previous top-down approaches in designing health policies for more participation and inclusion. The evidence synthesis played a crucial role in facilitating the debate. The collaborative approach seems to work in favouring national consensus on practical health financing actions. Conclusion: The policy dialogue process adopted for health financing in Morocco helped to create collective ownership of health financing actions. Despite the positive results in terms of national mobilisation around the health financing vision in Morocco, there is a need to institutionalise the policy dialogue with a more decentralised approach to consider subnational specificities.
- Open Access
- 15 March 2020
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 10 (5) , 237-243
Governance Roles and Capacities of Ministries of Health: A Multidimensional Framework
The lack of capacity for governance of Ministries of Health (MoHs) is frequently advanced as an explanation for health systems failures in low- and middle-income countries (LMICs). But do we understand what governance capacities MoHs should have? Existing frameworks have not fully captured the dynamic and contextually determined role of MoHs, and there are few frameworks that specifically define capacities for governance. We propose a multidimensional framework of capacities for governance by MoHs that encompasses both the "hard" (de jure, explicit and functional) and "soft" (de facto, tacit, and relational) dimensions of governance, and reflects the diversification of their mandates in the context of the Sustainable Development Goals (SDGs). Four case studies illustrate different aspects of the framework. We hope that the framework will have multiple potential benefits including benchmarking MoH governance capacities, identifying and helping analyze capacity gaps, and guiding strategies to strengthen capacity.
- 15 March 2020
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 10 (5) , 237-243
Open AccessGovernance Roles and Capacities of Ministries of Health: A Multidimensional Framework
The lack of capacity for governance of Ministries of Health (MoHs) is frequently advanced as an explanation for health systems failures in low- and middle-income countries (LMICs). But do we understand what governance capacities MoHs should have? Existing frameworks have not fully captured the dynamic and contextually determined role of MoHs, and there are few frameworks that specifically define capacities for governance. We propose a multidimensional framework of capacities for governance by MoHs that encompasses both the "hard" (de jure, explicit and functional) and "soft" (de facto, tacit, and relational) dimensions of governance, and reflects the diversification of their mandates in the context of the Sustainable Development Goals (SDGs). Four case studies illustrate different aspects of the framework. We hope that the framework will have multiple potential benefits including benchmarking MoH governance capacities, identifying and helping analyze capacity gaps, and guiding strategies to strengthen capacity.
- Open Access
- 30 August 2018
- Published by BMJ in BMJ Global Health
- Vol. 2 (Suppl 3) , e000941
Health systems research on access to medicines: unpacking challenges in implementing policies in the face of the epidemiological transition
Access to medicines is defined by WHO as ensuring that medicines are ‘available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and adequate information, and at a price the individual and community can afford’.1 The availability of essential medicines in public health facilities is often poor in the public sector of low-income and middle-income countries (LMICs). For selected generic medicines, availability is between 38% and 46%. Availability is better in the private sector but also suboptimal at around 70%.1 In some LMICs, prices of selected lowest priced generics can be more than twice the international reference prices, making these unaffordable for patients and the system.2 The recently concluded Lancet Commission on Essential Medicines for Universal Health Coverage has proposed a larger set of indicators that monitor the formulation and implementation of national medicines policies,3 including quality of essential medicines and disaggregation of indicators to reflect specific access issues for vulnerable populations. However, despite these efforts at defining, measuring and improving access, the underlying systemic causes of lack of access to medicines are seldom investigated. Bigdeli et al argue that access to medicines should be examined more broadly than within the narrow boundaries of the pharmaceutical sector4: critical factors determining medicines’ access are also found in other sub-systems of the health sector (including health financing, human resources for health and health information), at all levels from local to international and on both the supply-side and the demand-side. In 2011, the Alliance for Health Policy and Systems Research, WHO issued a call for research to generate new knowledge to inform this broad understanding of access to medicines.5 The objective of the call was to examine issues around access to medicines beyond the usual indicators …
- 30 August 2018
- Published by BMJ in BMJ Global Health
- Vol. 2 (Suppl 3) , e000941
Open AccessHealth systems research on access to medicines: unpacking challenges in implementing policies in the face of the epidemiological transition
Access to medicines is defined by WHO as ensuring that medicines are ‘available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and adequate information, and at a price the individual and community can afford’.1 The availability of essential medicines in public health facilities is often poor in the public sector of low-income and middle-income countries (LMICs). For selected generic medicines, availability is between 38% and 46%. Availability is better in the private sector but also suboptimal at around 70%.1 In some LMICs, prices of selected lowest priced generics can be more than twice the international reference prices, making these unaffordable for patients and the system.2 The recently concluded Lancet Commission on Essential Medicines for Universal Health Coverage has proposed a larger set of indicators that monitor the formulation and implementation of national medicines policies,3 including quality of essential medicines and disaggregation of indicators to reflect specific access issues for vulnerable populations. However, despite these efforts at defining, measuring and improving access, the underlying systemic causes of lack of access to medicines are seldom investigated. Bigdeli et al argue that access to medicines should be examined more broadly than within the narrow boundaries of the pharmaceutical sector4: critical factors determining medicines’ access are also found in other sub-systems of the health sector (including health financing, human resources for health and health information), at all levels from local to international and on both the supply-side and the demand-side. In 2011, the Alliance for Health Policy and Systems Research, WHO issued a call for research to generate new knowledge to inform this broad understanding of access to medicines.5 The objective of the call was to examine issues around access to medicines beyond the usual indicators …
- Open Access
- 22 August 2016
- Published by Springer Nature in BMC Health Services Research
- Vol. 16 (1) , 421
Improving access to medicines for non-communicable diseases in rural India: a mixed methods study protocol using quasi-experimental design
India has the distinction of financing its healthcare mainly through out-of-pocket expenses by individual families contributing to catastrophic health expenditure and impoverishment. Nearly 70 % of the expenditure is on medicines purchased at private pharmacies. Patients with chronic ailments are especially affected, as they often need lifelong medicines. Over the past years in India, there have been several efforts to improve drug availability at government primary health centres. In this study, we aim to understand health system factors that affect utilisation and access to generic medicines for people with non-communicable diseases. This study aims to understand if (and how) a package of interventions targeting primary health centres and community participation platforms affect utilisation and access to generic medicines for people with non-communicable diseases in the current district context in India. This study will employ a quasi-experimental design and a qualitative theory-driven approach. PHCs will be randomly assigned to one of three arms of the intervention. In one arm, PHCs will receive inputs to optimise service delivery for non-communicable diseases, while the second arm will receive an additional package of interventions to strengthen community participation platforms for improving non-communicable disease care. The third arm will be the control. We will conduct household and facility surveys, before and after the intervention and will estimate the effect of the intervention by difference-in-difference analysis. Sample size for measuring effects was calculated based on obtaining at least 30 households for each primary health centre spread across three distance-based clusters. Primary outcomes include availability and utilisation of medicines at primary health centres and out-of-pocket expenditure for medicines by non-communicable disease households. Focus group discussions with patients and in-depth interviews with health workers will also be conducted. Qualitative and process documentation data will be used to explain how the intervention could have worked. By taking into consideration several health system building blocks and trying to understand how they interact, our study aims to generate evidence for health planners on how to optimise health services to improve access to medicines. Protocol registered on Clinical Trials Registry of India with registration identifier number CTRI/2015/03/005640 on 17th March 2015.
- 22 August 2016
- Published by Springer Nature in BMC Health Services Research
- Vol. 16 (1) , 421
Open AccessImproving access to medicines for non-communicable diseases in rural India: a mixed methods study protocol using quasi-experimental design
India has the distinction of financing its healthcare mainly through out-of-pocket expenses by individual families contributing to catastrophic health expenditure and impoverishment. Nearly 70 % of the expenditure is on medicines purchased at private pharmacies. Patients with chronic ailments are especially affected, as they often need lifelong medicines. Over the past years in India, there have been several efforts to improve drug availability at government primary health centres. In this study, we aim to understand health system factors that affect utilisation and access to generic medicines for people with non-communicable diseases. This study aims to understand if (and how) a package of interventions targeting primary health centres and community participation platforms affect utilisation and access to generic medicines for people with non-communicable diseases in the current district context in India. This study will employ a quasi-experimental design and a qualitative theory-driven approach. PHCs will be randomly assigned to one of three arms of the intervention. In one arm, PHCs will receive inputs to optimise service delivery for non-communicable diseases, while the second arm will receive an additional package of interventions to strengthen community participation platforms for improving non-communicable disease care. The third arm will be the control. We will conduct household and facility surveys, before and after the intervention and will estimate the effect of the intervention by difference-in-difference analysis. Sample size for measuring effects was calculated based on obtaining at least 30 households for each primary health centre spread across three distance-based clusters. Primary outcomes include availability and utilisation of medicines at primary health centres and out-of-pocket expenditure for medicines by non-communicable disease households. Focus group discussions with patients and in-depth interviews with health workers will also be conducted. Qualitative and process documentation data will be used to explain how the intervention could have worked. By taking into consideration several health system building blocks and trying to understand how they interact, our study aims to generate evidence for health planners on how to optimise health services to improve access to medicines. Protocol registered on Clinical Trials Registry of India with registration identifier number CTRI/2015/03/005640 on 17th March 2015.
- Open Access
- 27 January 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (1) , e0146147
Access to Treatment for Diabetes and Hypertension in Rural Cambodia: Performance of Existing Social Health Protection Schemes
Non-communicable diseases (NCD) pose challenges to Cambodia’s health system. Medicines for NCD are on the National Essential Medicines List but no clinical guidelines support their utilization. Two social health protection schemes aimed at the informal sector population exist (Health Equity Funds and Insurance) together with two disease-specific interventions (a Peer Educator Network and Chronic Diseases Clinics) targeted at NCD patients. This study examines performance of these various schemes in relation to NCD. Cross-sectional household survey among 709 individuals self-reporting diabetes and/or hypertension in three geographical locations in rural Cambodia using a structured questionnaire investigating diagnostic and treatment pathways, health seeking behaviour, health expenditures, and financial coping mechanisms. Two third of respondents with NCD were female and 55% did not belong to any scheme. The majority (59%) were diagnosed in the private sector and only 56% were on allopathic treatment that was mainly sought in the private sector (49%). Outpatient treatment cost was higher in the private sector and when using multiple providers of care. The majority were indebted, 11% due to health-related expenses. Contrary to social health protection schemes, disease-specific interventions offered better access to allopathic treatment and provided medicines in accordance with NEML. The benefit packages of existing social health protection schemes and services in the public health sector should be adjusted to cater for the needs of people living with NCD in rural Cambodia. Initiatives that offer active disease management strategies and promote patients and community participation appear more successful in increasing treatment adherence and decreasing the risk of financial hardship.
- 27 January 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (1) , e0146147
Open AccessAccess to Treatment for Diabetes and Hypertension in Rural Cambodia: Performance of Existing Social Health Protection Schemes
Non-communicable diseases (NCD) pose challenges to Cambodia’s health system. Medicines for NCD are on the National Essential Medicines List but no clinical guidelines support their utilization. Two social health protection schemes aimed at the informal sector population exist (Health Equity Funds and Insurance) together with two disease-specific interventions (a Peer Educator Network and Chronic Diseases Clinics) targeted at NCD patients. This study examines performance of these various schemes in relation to NCD. Cross-sectional household survey among 709 individuals self-reporting diabetes and/or hypertension in three geographical locations in rural Cambodia using a structured questionnaire investigating diagnostic and treatment pathways, health seeking behaviour, health expenditures, and financial coping mechanisms. Two third of respondents with NCD were female and 55% did not belong to any scheme. The majority (59%) were diagnosed in the private sector and only 56% were on allopathic treatment that was mainly sought in the private sector (49%). Outpatient treatment cost was higher in the private sector and when using multiple providers of care. The majority were indebted, 11% due to health-related expenses. Contrary to social health protection schemes, disease-specific interventions offered better access to allopathic treatment and provided medicines in accordance with NEML. The benefit packages of existing social health protection schemes and services in the public health sector should be adjusted to cater for the needs of people living with NCD in rural Cambodia. Initiatives that offer active disease management strategies and promote patients and community participation appear more successful in increasing treatment adherence and decreasing the risk of financial hardship.
- Open Access
- 21 January 2016
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 9 (1) , 1-11
Patient-centred innovation to ensure access to diabetes care in Cambodia: the case of MoPoTsyo
Background: The increasing prevalence of chronic diseases puts a high burden on the health care systems of Low and Middle Income Countries which are often not adapted to provide the care needed. Peer support programmes are promoted to address health system constraints. This case study analyses a peer educator diabetes programme in Cambodia, MoPoTsyo, from a health system’s perspective. Which strategies were used and how did these strategies change? How is the programme perceived? Methods: Data were collected through semi-structured interviews with patients, MoPoTsyo staff and peer educators, contracted pharmacy staff and health workers, health care workers and non-contracted pharmacists and managers and policy makers at district, provincial and national level. Four areas were purposively selected to do the interviews. An inductive content analysis was done independently by two researchers. Results: MoPoTsyo developed into three stages: a focus on diabetes self-management; a widening scope to ensure affordable medicines and access to other health care services; and aiming for sustainability through more integration with the Cambodian public system and further upscaling. All respondents acknowledged the peer educators’ role and competence in patient education, but their ideas about additional tasks and their place in the system differed. Indirectly involved stakeholders and district managers emphasized the particular roles and responsibilities of all actors in the system and the particular role of the peer educator in the community. MoPoTsyo’s diagnostics and laboratory services were perceived as useful, especially by patients and project staff. Respondents were positive about the revolving drug fund, but expressed concerns about its integration into the government system. The degree of collaboration between health care staff and peer educators varied. Conclusion: MoPoTsyo responds to the needs of people with diabetes in Cambodia. Key success factors were: consistent focus on and involvement of the target group, backed up by a strong organisation; simultaneous reduction of other barriers to care; and the ongoing maintenance of relations at all levels within the health system. Despite resistance, MoPoTsyo has established a more balanced relationship between patients and health service providers, empowering patients to self-manage and access services that meet their needs.
- 21 January 2016
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 9 (1) , 1-11
Open AccessPatient-centred innovation to ensure access to diabetes care in Cambodia: the case of MoPoTsyo
Background: The increasing prevalence of chronic diseases puts a high burden on the health care systems of Low and Middle Income Countries which are often not adapted to provide the care needed. Peer support programmes are promoted to address health system constraints. This case study analyses a peer educator diabetes programme in Cambodia, MoPoTsyo, from a health system’s perspective. Which strategies were used and how did these strategies change? How is the programme perceived? Methods: Data were collected through semi-structured interviews with patients, MoPoTsyo staff and peer educators, contracted pharmacy staff and health workers, health care workers and non-contracted pharmacists and managers and policy makers at district, provincial and national level. Four areas were purposively selected to do the interviews. An inductive content analysis was done independently by two researchers. Results: MoPoTsyo developed into three stages: a focus on diabetes self-management; a widening scope to ensure affordable medicines and access to other health care services; and aiming for sustainability through more integration with the Cambodian public system and further upscaling. All respondents acknowledged the peer educators’ role and competence in patient education, but their ideas about additional tasks and their place in the system differed. Indirectly involved stakeholders and district managers emphasized the particular roles and responsibilities of all actors in the system and the particular role of the peer educator in the community. MoPoTsyo’s diagnostics and laboratory services were perceived as useful, especially by patients and project staff. Respondents were positive about the revolving drug fund, but expressed concerns about its integration into the government system. The degree of collaboration between health care staff and peer educators varied. Conclusion: MoPoTsyo responds to the needs of people with diabetes in Cambodia. Key success factors were: consistent focus on and involvement of the target group, backed up by a strong organisation; simultaneous reduction of other barriers to care; and the ongoing maintenance of relations at all levels within the health system. Despite resistance, MoPoTsyo has established a more balanced relationship between patients and health service providers, empowering patients to self-manage and access services that meet their needs.
- Open Access
- 1 December 2015
- Published by Springer Nature in BMC Health Services Research
- Vol. 16 (1) , 1-12
Managing non-communicable diseases at health district level in Cambodia: a systems analysis and suggestions for improvement
Cambodia developed its public health system along the principles of the district model and geared its services towards managing communicable diseases and maternal and child health issues. In line with other countries in the region, non-communicable diseases have emerged as a leading cause of adult mortality. We assessed the current capacity of the Cambodian district health system to manage hypertension and diabetes, with a focus on access to medicine for these chronic conditions. A case study whereby in three purposely selected districts in an equal number of provinces a total of 74 informants were interviewed: 27 health care providers and administrators, 30 community representatives and 17 managers of specific non-communicable diseases interventions and social health protection schemes. Questions related to the World Health Organization’s health system building blocks. Data analysis involved coding, indexing, charting and mapping the data. Following these exercises all information was analysed by kind of respondent and their respective answer to the question concerned. Responses by respondents of three groups of interviewees were compared when appropriate. At 14 health centres and 3 district hospitals the availability of key medicines for hypertension and diabetes in accordance with the National Essential Drug List was assessed. This was also done for essential tools and equipment to diagnose these two conditions. Although there was agreement amongst nearly all interviewees that non-communicable diseases were prevalent, the district health system, including all health systems building blocks and the referral system, was inadequately developed to effectively deal with these conditions. Medicines supply was erratic and the quantity provided allowed for few patients to be treated, for a short period only, mainly at secondary or tertiary level. Because of the public health, social and economic importance of non-communicable diseases, a rapid response is required. Given the current Cambodian situation, such response may initially be a diagonal approach, with non-communicable diseases services integrated in the National HIV/AIDS Programme. This should happen together with a reorientation of the health system to enable a horizontal approach to non-communicable diseases management in the long term.
- 1 December 2015
- Published by Springer Nature in BMC Health Services Research
- Vol. 16 (1) , 1-12
Open AccessManaging non-communicable diseases at health district level in Cambodia: a systems analysis and suggestions for improvement
Cambodia developed its public health system along the principles of the district model and geared its services towards managing communicable diseases and maternal and child health issues. In line with other countries in the region, non-communicable diseases have emerged as a leading cause of adult mortality. We assessed the current capacity of the Cambodian district health system to manage hypertension and diabetes, with a focus on access to medicine for these chronic conditions. A case study whereby in three purposely selected districts in an equal number of provinces a total of 74 informants were interviewed: 27 health care providers and administrators, 30 community representatives and 17 managers of specific non-communicable diseases interventions and social health protection schemes. Questions related to the World Health Organization’s health system building blocks. Data analysis involved coding, indexing, charting and mapping the data. Following these exercises all information was analysed by kind of respondent and their respective answer to the question concerned. Responses by respondents of three groups of interviewees were compared when appropriate. At 14 health centres and 3 district hospitals the availability of key medicines for hypertension and diabetes in accordance with the National Essential Drug List was assessed. This was also done for essential tools and equipment to diagnose these two conditions. Although there was agreement amongst nearly all interviewees that non-communicable diseases were prevalent, the district health system, including all health systems building blocks and the referral system, was inadequately developed to effectively deal with these conditions. Medicines supply was erratic and the quantity provided allowed for few patients to be treated, for a short period only, mainly at secondary or tertiary level. Because of the public health, social and economic importance of non-communicable diseases, a rapid response is required. Given the current Cambodian situation, such response may initially be a diagonal approach, with non-communicable diseases services integrated in the National HIV/AIDS Programme. This should happen together with a reorientation of the health system to enable a horizontal approach to non-communicable diseases management in the long term.